Assignee
NOVEOME BIOTHERAPEUTICS INC
US·4 granted patents·22 pending applications·7 citations·filing 2014–2024
Top patents by PatentIndex Score
26 records- 0189US9980987B2Treatment of diseases and conditions caused by increased vascular permeabilityNOVEOME BIOTHERAPEUTICS INC·Filed 2017·Granted May 29, 2018·6 cites·1 claims
- 0286US2025025514A1Treatment of systemic inflammatory responsesNOVEOME BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0382US10286015B2Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cellsNOVEOME BIOTHERAPEUTICS INC·Filed 2017·Granted May 14, 2019·1 cites·6 claims
- 0477US2022030851A1Modulating ischemic injuryNOVEOME BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0574US12121546B2Treatment of systemic inflammatory responsesNOVEOME BIOTHERAPEUTICS INC·Filed 2021·Granted Oct 22, 2024·0 cites·7 claims
- 0670US2020085735A1Novel methods for delivering therapeutics agents to the eye via the nasal passagesNOVEOME BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0769US2018288998A1Modulating Ischemic InjuryNOVEOME BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0869US2020261512A1Treatment of Diseases and Conditions Caused by Increased Vascular PermeabilityNOVEOME BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0965US2018271916A1Treatment of diseases and conditions caused by increased vascular permeabilityNOVEOME BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1064US2018207091A1Novel methods for delivering therapeutic agents to the eye via nasal passagesNOVEOME BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1164US2016367603A1Methods for Modulating Skin InflammationNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1259US2016361253A1Novel Methods for Delivering Therapeutic Agents to the Eye via Nasal PassagesNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1358US2020147145A1Methods for Reducing the Extent of Light-induced Tissue Inflammation and InjuryNOVEOME BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1457US2016220615A1Methods for treating ophthalmic disorders, diseases and injuriesNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1555US2018271914A1Methods for Reducing the Extent of Light-induced Tissue Inflammation and InjuryNOVEOME BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1654US2017202919A1Methods for preventing or treating optic neuritisNOVEOME BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1754US2017136101A1Methods for preventing and/or treating nasal polyps and rhinosinusitisNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1854US2024066071A1Secretome fractions and uses thereofNOVEOME BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1954US2017209498A1Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerveNOVEOME BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2053US2021290728A1Use of ST266 to Treat Severe Systemic Inflammation and Post-Acute COVID-19 SyndromeNOVEOME BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2152US2016324928A1Methods for treating blepharitisNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2252US2016367602A1Methods for treating hidradenitis suppurativaNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2348US2016220617A1Methods for treating cartilage disorders, diseases and injuriesNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2440US2016296606A1Cellular Factor-Containing Solution Compositions for the Treatment of Rhinovirus Infection and SymptomsNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2540US2017035812A1Novel cell-derived compositionNOVEOME BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2638US9802010B2Interproximal drug delivery deviceNOVEOME BIOTHERAPEUTICS INC·Filed 2014·Granted Oct 31, 2017·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →